Device manufacturer iSonea believes it is on the cusp of securing the CE mark to market its asthma monitoring device called the AirSonea Wheeze Monitor. The company is working to potentially launch the device in Europe after an anticipated U.S. release of the product next year. The company also is preparing to release the product this month in Australia.

Full Story:
BioSpectrum Asia

Related Summaries